Biohybrid cochlear implants: neural interfaces, regenerative pathways, and translational benchmarks.
Akihiro J Matsuoka, Andrew N Carpino, Audrey Meador and 9 others
PMID 42380881WHAT IT FOUND
Current cochlear implants leave a 0.5 to 2 mm gap between electrodes and auditory neurons, limiting how independently sound channels can work.
A proposed biohybrid idea uses tiny native channels to guide nerve regrowth and growth factor support, but no method is clinically validated.
Key findings
01Current cochlear implant electrodes typically sit 0.5 to 2 mm from spiral ganglion neurons, which reduces channel selectivity.
02The native cochlear microchannels are 0.2 to 27 micrometers wide, too small for an electrode but sized to carry neurotrophins and regenerating neurites.
03No reviewed preclinical strategy has yet matured into a safe, scalable, clinically validated method to narrow the electrode-neuron gap or improve perceptual outcomes.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review, not a patient study; it reports no new clinical outcomes. The proposed biohybrid implant has not been tested in humans. The paper does not describe a systematic search or quality assessment of the cited literature. Many supporting claims come from anatomical, animal, or in vitro studies that are not detailed here. The authors' conclusions are a framework for future research, not evidence of benefit.
The easy way to misread this
Do not read this as evidence that biohybrid cochlear implants work or are clinically available. The paper is a conceptual review, and it states that no current strategy has matured into a safe, scalable, clinically validated method to narrow the electrode-neuron gap or improve perceptual outcomes.